ApoL9 localizes to small cytosolic puncta and larger granules that resemble ALIS.
ApoL9 specifically binds the phospholipid phosphatidylethanolamine.
B16F10 melanoma cells expressing ApoL9 produce increased JEV titres on infection.
Using lipofection in studies involving ApoL9 might lead to biological artefacts.